Retatrutide is a newly discovered compound that shows promise as a treatment for type 2 diabetes. It functions as a agonist of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://deacondjgy506821.blogolenta.com/36119224/semaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes